ACE

Chr 17AR

angiotensin I converting enzyme

Also known as: ACE1, CD143, DCP, DCP1

This gene encodes angiotensin converting enzyme, a dipeptidyl carboxypeptidase that converts angiotensin I to angiotensin II and inactivates bradykinin, thereby regulating blood pressure and electrolyte balance, and also cleaves various neuropeptides involved in synaptic transmission. Mutations cause autosomal recessive renal tubular dysgenesis, a severe condition presenting in the perinatal period with oligohydramnios, intrauterine growth restriction, and neonatal anuria. The gene shows low constraint against loss-of-function variants in the general population (LOEUF 1.08).

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismARLOEUF 1.083 OMIM phenotypes
Clinical SummaryACE
🧬
Gene-Disease Validity (ClinGen)
renal tubular dysgenesis - ACE · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
💊
Clinical Trials
12 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.08LOEUF
pLI 0.000
Z-score 0.98
OE 0.87 (0.711.08)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.69Z-score
OE missense 1.07 (1.011.14)
797 obs / 743.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.87 (0.711.08)
00.351.4
Missense OE1.07 (1.011.14)
00.61.4
Synonymous OE1.24
01.21.6
LoF obs/exp: 62 / 70.9Missense obs/exp: 797 / 743.8Syn Z: -3.33
DN
0.6161th %ile
GOF
0.6931th %ile
LOF
0.3065th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ACE · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Adverse Childhood ExperiencesDevelopmental RiskPsychomotor Development Disorders

Growing Up in Multifactorial Risk Conditions

ENROLLING BY INVITATION
NCT07477899Phase NAIRCCS Eugenio MedeaStarted 2024-06-26
Home visiting programme
Autoimmune Hypothyroidism

LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.

RECRUITING
NCT05682482Phase PHASE3M. MediciStarted 2022-10-07
LT3 (liothyronine)Placebo
Lymphoma, Large B-Cell, Diffuse

Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis

ACTIVE NOT RECRUITING
NCT03293173Phase PHASE2Nordic Lymphoma GroupStarted 2017-08-04
R-CHOEPDA-EPOCH-R
Asthma

Genetic Association With Various Severities, Phenotypes and Endotypes of Asthma.

RECRUITING
NCT06196034Chinese University of Hong KongStarted 2024-03-01
No intervention
Decompensated Cirrhosis

Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis

NOT YET RECRUITING
NCT06533852Phase PHASE3Consorcio Centro de Investigación Biomédica en Red (CIBER)Started 2024-12
Fecal Microbiome Transplantation (FMT)FMT Placebo
Chronic Kidney DiseasesHemodialysis Complication

Clinical Outcomes of Hemodialysis in Brazil (COHEBRA): a Prospective Cohort Study

ENROLLING BY INVITATION
NCT05273424Catholic University of PelotasStarted 2017-06-01
Chronic Kidney DiseasesMAFLD

Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.

NOT YET RECRUITING
NCT07391267Phase NAInstitute of Liver and Biliary Sciences, IndiaStarted 2026-02-01
Semaglutide Oral TabletPlaceboStandard medical treatment
Cancer

Onco Move - Improvement of Psychophysical Fitness in Adult Cancer Survivors

NOT YET RECRUITING
NCT07087652Phase NAGdansk University of Physical Education and SportStarted 2025-09-01
Onco Move multicomponent face-to-face training program
Epigenetic Effects of Intranasal SteroidsEnvironmental Exposure

Epigenetic Health Benefits of Budesonide

ACTIVE NOT RECRUITING
NCT04342039Phase PHASE4University of British ColumbiaStarted 2021-01-07
Budesonide NasalPlacebo
Alport Syndrome

Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants

NOT YET RECRUITING
NCT05133050Phase NAXinhua Hospital, Shanghai Jiao Tong University School of MedicineStarted 2022-01-01
Ramipril
Bronchiolitis Obliterans Syndrome (BOS)

Mechanisms and Targeted Therapy of Airway Basal Cell Dysfunction in Bronchiolitis Obliterans Syndrome

ENROLLING BY INVITATION
NCT07018804Phase NAHaikou Affiliated Hospital of Central South University Xiangya School of MedicineStarted 2026-01-01
Bronchoscopic brushingSingle - cell cloningCell function identification
Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor

Bradykinin-degradating Enzymes Activities in Angiotensin-Converting Enzyme Inhibitors-associated Angioedema

RECRUITING
NCT04763577University Hospital, GrenobleStarted 2021-10-27
Assay of Bradykinin-degradating enzymes.
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
ACE Inhibitors
Goyal A et al.
2022
Update on ACER.
Miles MF·Alcohol Clin Exp Res (Hoboken)
2024
A Pair of "ACEs".
Hersh EV et al.·J Dent Res
2022
Launching the ACE.
Calvert K et al.·Aust N Z J Obstet Gynaecol
2024
Top 5 full-text resultsSearch PubTator3 ↗